AFT Pharmaceuticals Ltd (ASX:AFP)
A$ 2.55 -0.02 (-0.78%) Market Cap: 247.03 Mil Enterprise Value: 265.29 Mil PE Ratio: 18.46 PB Ratio: 3.31 GF Score: 88/100

Full Year 2021 AFT Pharmaceuticals Ltd Earnings Call Transcript

May 23, 2021 / 10:00PM GMT
Hartley Atkinson
AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director

Good. Thank you very much, and thanks for joining us today. Look, just to go through the presentation that we have up on the NZX. So it's the Investor Presentation May 2021. So that's the cover page. And flicking through, if you could, please, to Page 2, are the disclaimers. So you could just be aware of those. Thank you.

And then moving on to the main part of the presentation itself on Page 3, AFT financials at a glance. So here, we've just tried to show you the sales progress. Look, literally, the top graph showing the sales over a period of time, we've had our 23rd year of uninterrupted sales growth. So we were pleased during the global pandemic to still be able to grow our sales line from $106 million the year before to $113 million this financial year.

And on the bottom of the page, we have operating profit and profit after tax. So the operating profit, you'll note that, that was $10.7 million. And that was slightly down from last year, $11.4 million. We had a -- last year, we had some effects

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot